ATE338754T1 - Heterocyclische verbindungen, ihre herstellung und verwendung - Google Patents
Heterocyclische verbindungen, ihre herstellung und verwendungInfo
- Publication number
- ATE338754T1 ATE338754T1 AT02079001T AT02079001T ATE338754T1 AT E338754 T1 ATE338754 T1 AT E338754T1 AT 02079001 T AT02079001 T AT 02079001T AT 02079001 T AT02079001 T AT 02079001T AT E338754 T1 ATE338754 T1 AT E338754T1
- Authority
- AT
- Austria
- Prior art keywords
- stands
- heterocyclic compounds
- chem
- denotes
- integer
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19110096 | 1996-07-19 | ||
| JP15517797 | 1997-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338754T1 true ATE338754T1 (de) | 2006-09-15 |
Family
ID=26483246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02079001T ATE338754T1 (de) | 1996-07-19 | 1997-07-17 | Heterocyclische verbindungen, ihre herstellung und verwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6211215B1 (de) |
| EP (2) | EP0912562A1 (de) |
| KR (1) | KR20000065227A (de) |
| CN (2) | CN1077107C (de) |
| AT (1) | ATE338754T1 (de) |
| AU (1) | AU3461697A (de) |
| CA (1) | CA2260999C (de) |
| DE (1) | DE69736642T2 (de) |
| ID (1) | ID17851A (de) |
| WO (1) | WO1998003505A2 (de) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| IL133007A (en) * | 1997-05-28 | 2005-06-19 | Aventis Pharma Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| DE69802422T3 (de) † | 1997-08-15 | 2005-12-29 | Cephalon, Inc. | Kombination von tyrosinkinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs |
| CN1322139A (zh) * | 1998-10-08 | 2001-11-14 | 武田药品工业株式会社 | 阻滞激素依赖性癌症向激素非依赖性癌症转化的药物 |
| US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| AU1412901A (en) * | 1999-11-16 | 2001-05-30 | Toray Industries, Inc. | Benzene derivatives and use thereof as drugs |
| PE20011178A1 (es) * | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
| CA2414461A1 (en) | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| KR20040101564A (ko) * | 2000-07-19 | 2004-12-02 | 다케다 야쿠힌 고교 가부시키가이샤 | 1-치환-1,2,3-트리아졸 유도체, 그 중간체, 및 이들의제조 방법 |
| CA2431322A1 (en) * | 2000-12-11 | 2002-06-20 | Eiji Nara | Medicinal compositions having improved absorbability |
| EP1712550A3 (de) * | 2000-12-22 | 2009-07-15 | Ortho-McNeil Pharmaceutical, Inc. | Substituite Triazoldiamin Derivate und ihre Verwendung als Kinase-Inhibitoren |
| DE60139025D1 (de) | 2000-12-28 | 2009-07-30 | Takeda Pharmaceutical | Alkansäurederivate, verfahren zu deren herstellung und deren verwendung |
| SE0100567D0 (sv) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| WO2002087619A1 (fr) * | 2001-04-27 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Methode de prevention et de traitement du cancer |
| US20040116330A1 (en) * | 2001-04-27 | 2004-06-17 | Kenichiro Naito | Preventive/therapeutic method for cancer |
| IL159320A0 (en) | 2001-06-12 | 2004-06-01 | Wellstat Therapeutics Corp | Compounds for the treatment of metabolic disorders |
| EP1439178A4 (de) * | 2001-10-05 | 2005-11-16 | Takeda Pharmaceutical | Heterocyclische verbindungen, oxazolderivate, verfahren zu deren herstellung und deren verwendung |
| WO2003041739A1 (en) | 2001-11-13 | 2003-05-22 | Takeda Chemical Industries, Ltd. | Anticaner agents |
| EP1460067A4 (de) * | 2001-11-26 | 2005-12-07 | Takeda Pharmaceutical | Bicyclische derivate, verfahren zu deren herstellung und deren verwendung |
| WO2003059907A1 (fr) * | 2002-01-17 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Composes heterocycliques azotes : procede de preparation et d'utilisation |
| DE10258168B4 (de) * | 2002-12-12 | 2005-07-07 | Infineon Technologies Ag | Integrierter DRAM-Halbleiterspeicher und Verfahren zum Betrieb desselben |
| WO2004073611A2 (en) | 2003-02-13 | 2004-09-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| TW200505913A (en) * | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| AR044098A1 (es) * | 2003-04-30 | 2005-08-24 | Hoffmann La Roche | Derivados de anilina, su elaboracion, composiciones farmaceuticas y su uso para elaborar medicamentos para el tratamiento del cancer |
| US7247649B2 (en) | 2003-08-13 | 2007-07-24 | Hoffmann-La Roche Inc. | Oxazoles, their manufacture and use as pharmaceutical agents |
| CA2532026C (en) * | 2003-08-20 | 2012-04-17 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| ES2286679T3 (es) * | 2003-08-20 | 2007-12-01 | Eli Lilly And Company | Compuestos, procedimientos y formulaciones para la liberacion oral de un compuesto de peptido de tipo glucagon (glp)-1 o un peptido agonist a del receptor de melanocortina 4 (mc4). |
| US7259262B2 (en) | 2003-10-24 | 2007-08-21 | Hoffmann-La Roche Inc. | Arylazole derivatives, their manufacture and use as pharmaceutical agents |
| TW200612914A (en) | 2004-03-05 | 2006-05-01 | Hoffmann La Roche | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |
| TW200531688A (en) | 2004-03-05 | 2005-10-01 | Hoffmann La Roche | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
| TW200533346A (en) | 2004-03-18 | 2005-10-16 | Hoffmann La Roche | Novel ether derivatives, their manufacture and use as pharmaceutical agents |
| KR20060131958A (ko) | 2004-04-02 | 2006-12-20 | 에프. 호프만-라 로슈 아게 | 디아진 유도체의 신규한 제조 방법 |
| US7163953B2 (en) | 2004-05-25 | 2007-01-16 | Hoffmann-La Roche Inc. | Benzylether derivatives |
| US7005526B2 (en) | 2004-05-25 | 2006-02-28 | Hoffmann-La Roche Inc. | Thioether derivatives |
| US7288557B2 (en) | 2004-09-21 | 2007-10-30 | Hoffmann-La Roche Inc. | Triazole derivatives |
| TW200616951A (en) * | 2004-09-22 | 2006-06-01 | Hoffmann La Roche | Indole derivatives, their manufacture and use as pharmaceutial agents |
| US20060069095A1 (en) * | 2004-09-24 | 2006-03-30 | Thomas Hofmeister | Azole derivatives |
| US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
| KR20080041662A (ko) | 2005-07-22 | 2008-05-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 조기 배란 예방제 |
| TW200738680A (en) * | 2005-08-04 | 2007-10-16 | Hoffmann La Roche | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| WO2007017222A1 (en) * | 2005-08-08 | 2007-02-15 | F. Hoffmann-La Roche Ag | Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| CA2634442A1 (en) * | 2005-12-22 | 2007-07-05 | Icagen, Inc. | Calcium channel antagonists |
| WO2008034579A1 (en) * | 2006-09-20 | 2008-03-27 | F. Hoffmann-La Roche Ag | 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents |
| WO2008151437A1 (en) * | 2007-06-14 | 2008-12-18 | Osta Biotechnologies | Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system |
| JPWO2010026993A1 (ja) | 2008-09-03 | 2012-02-02 | 武田薬品工業株式会社 | 製剤における吸収性改善方法および吸収性が改善された製剤 |
| EP2902014B1 (de) | 2012-09-26 | 2019-03-06 | Takeda Pharmaceutical Company Limited | Verfahren zur herstellung von festen teilchen |
| CA2995617A1 (en) * | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
| CN117624052B (zh) * | 2024-01-26 | 2024-04-12 | 四川益能康生环保科技有限公司 | 一种用于捕集二氧化碳的离子液体及其制备方法 |
| CN117820251B (zh) * | 2024-03-01 | 2024-05-03 | 南京桦冠生物技术有限公司 | 双α-酮酸酰胺类化合物及其组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
| CA2087437A1 (en) | 1990-08-23 | 1992-02-24 | Steven W. Goldstein | Hypoglycemic hydroxyurea derivatives |
| WO1994003427A1 (en) | 1992-08-06 | 1994-02-17 | Warner-Lambert Company | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| IT1266582B1 (it) | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
| US5466610A (en) | 1993-09-07 | 1995-11-14 | Eli Lilly And Company | Immunoassays for insulin sensitivity enhancers, insulin sensitivity enhancer antibodies, and non-thiazolidinedione insulin sensitivity enhancer compositions |
| US5480896A (en) | 1994-01-27 | 1996-01-02 | American Home Products Corporation | Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents |
| HU222181B1 (hu) * | 1994-09-29 | 2003-04-28 | Novartis Ag. | Pirrolo/2,3-d/pirimidinek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények |
-
1997
- 1997-07-17 AT AT02079001T patent/ATE338754T1/de not_active IP Right Cessation
- 1997-07-17 EP EP97930819A patent/EP0912562A1/de not_active Withdrawn
- 1997-07-17 AU AU34616/97A patent/AU3461697A/en not_active Abandoned
- 1997-07-17 CN CN97195822A patent/CN1077107C/zh not_active Expired - Fee Related
- 1997-07-17 US US09/180,955 patent/US6211215B1/en not_active Expired - Fee Related
- 1997-07-17 KR KR1019980709698A patent/KR20000065227A/ko not_active Application Discontinuation
- 1997-07-17 DE DE69736642T patent/DE69736642T2/de not_active Expired - Lifetime
- 1997-07-17 CA CA002260999A patent/CA2260999C/en not_active Expired - Fee Related
- 1997-07-17 EP EP02079001A patent/EP1270571B1/de not_active Expired - Lifetime
- 1997-07-17 WO PCT/JP1997/002479 patent/WO1998003505A2/en not_active Application Discontinuation
- 1997-07-21 ID IDP972526A patent/ID17851A/id unknown
-
2001
- 2001-05-18 CN CN01119519A patent/CN1349990A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000065227A (ko) | 2000-11-06 |
| US6211215B1 (en) | 2001-04-03 |
| CA2260999C (en) | 2006-07-11 |
| CN1223653A (zh) | 1999-07-21 |
| EP0912562A1 (de) | 1999-05-06 |
| ID17851A (id) | 1998-01-29 |
| DE69736642T2 (de) | 2007-09-20 |
| CA2260999A1 (en) | 1998-01-29 |
| DE69736642D1 (de) | 2006-10-19 |
| WO1998003505A2 (en) | 1998-01-29 |
| CN1349990A (zh) | 2002-05-22 |
| CN1077107C (zh) | 2002-01-02 |
| EP1270571A1 (de) | 2003-01-02 |
| EP1270571B1 (de) | 2006-09-06 |
| WO1998003505A3 (en) | 1998-06-25 |
| AU3461697A (en) | 1998-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE338754T1 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung | |
| DE69111029D1 (de) | Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung. | |
| DE69636086D1 (de) | Sauerstoff enthaltende heterocyclische verbindungen | |
| DE69523358D1 (de) | Heterozyklische Verbindungen mit antidiabetischer Wirkung, ihre Herstellung und Verwendung | |
| NO953305D0 (no) | Antranilsyrederivat | |
| DE69023171T2 (de) | Kondensierte heterozyklische Verbindungen, ihre Herstellung und Verwendung. | |
| ATE339409T1 (de) | Trizyklische verbindungen | |
| DE69431576D1 (de) | Isoxazole Derivate und ihre Verwendung als Herbizide | |
| DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| HU9301866D0 (en) | Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition | |
| ATE497948T1 (de) | Bicyclische verbindungen | |
| DE69202120T2 (de) | Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie. | |
| DE60037766D1 (de) | Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate | |
| DE69319859D1 (de) | Neue tetracyclische verbindungen | |
| ATE303376T1 (de) | Tricyclische kondensierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
| GR3031390T3 (en) | Fluoropropene compound, an insecticide containing the same and an intermediate for production thereof | |
| MY134476A (en) | Aromatic compounds, their production processes and their compositions for the control of insect pests |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |